YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy

Clinical trial NCT00899093 · TERMINATED

Trial details

NCT number: NCT00899093
Sponsor: Gynecologic Oncology Group
Status: TERMINATED
Study type: OBSERVATIONAL

Fallopian Tube Adenocarcinoma Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma Fallopian Tube Serous Adenocarcinoma Fallopian Tube Transitional Cell Carcinoma Malignant Ovarian Brenner Tumor Malignant Ovarian Clear Cell Tumor Malignant Ovarian Endometrioid Tumor Malignant Ovarian Mixed Epithelial Tumor Malignant Ovarian Mucinous Tumor Malignant Ovarian Neoplasm

Start date: 2007-09-01
Primary completion: 2016-06-01
Enrollment: 2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.